PLAU anticorps (N-Term)

N° du produit ABIN2853629

Détail du produit anti-PLAU anticorps

Antigène: PLAU (Plasminogen Activator, Urokinase (PLAU))

Épitope: AA 68-98, N-Term

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PLAU est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Specificité: This antibody recognizes Urokinase/PLAU (N-term).

Purification: Protein G Chromatography, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS

Immunogène: This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between aa 68-98 from the N-terminal region of human PLAU.

Information d'application

Indications d'application: ELISA: 1/1,000. Western blotting: 1/100-1/500. Immunohistochemistry: 1/50-1/100. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.25 mg/mL

Buffer: PBS with 0.09% (w/v) Sodium Azide as preservative.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store the antibody undiluted at 2-8°C for one month or (in aliquots) at-20°C for longer.

Date de péremption: 12 months

Détails sur PLAU

Antigène: PLAU (Plasminogen Activator, Urokinase (PLAU))

Autre désignation: uPA / PLAU (PLAU Produits)

Synonymes: anticorps PLAU, anticorps u-PA, anticorps ATF, anticorps BDPLT5, anticorps QPD, anticorps UPA, anticorps URK, anticorps uPA, anticorps UPAM, anticorps plasminogen activator, urokinase, anticorps urokinase-type plasminogen activator, anticorps PLAU, anticorps CpipJ_CPIJ002131, anticorps CpipJ_CPIJ006543, anticorps CpipJ_CPIJ013396, anticorps CpipJ_CPIJ013623, anticorps Plau

Sujet: PLAU, a member of the peptidase family S1, is a potent plasminogen activator and is clinically used for therapy of thrombolytic disorders. PLAU specifically cleaves the Arg-|-Val bond in plasminogen to form plasmin. The protein is found in high and low molecular mass forms. Each consists of two chains, A and B. The high molecular mass form contains a long chain A. Cleavage occurs after residue 155 in the low molecular mass form to yield a short A1 chain. The protein is used in Pulmonary Embolism (PE) to initiates fibrinolysis. Structurally, PLAU contains 1 EGF-like domain and 1 kringle domain.
Alternate names: U-plasminogen activator, Urokinase, Urokinase-type plasminogen activator, Urokinase- type plasminogen activator chain B, Urokinase-type plasminogen activator long chain A, Urokinase-type plasminogen activator short chain A

ID gène: 5328, 9606

UniProt: P00749

Pathways: Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Autophagy, Smooth Muscle Cell Migration